Kintara Therapeutics Inc. Soared
Thu, Mar 16, 2023 at 07:11 PM
Kintara Therapeutics Inc. (KTRA:NASDAQ) jumped higher at $4.41, representing a gain of 34%. The stock appeared on our News Catalysts scanner on Wed, Mar 15, 2023 at 09:20 AM in the 'BIOTECH' category. From Thu, Mar 02, 2023, the stock recorded 30.00% Up Days and 45.45% Green Days
About Kintara Therapeutics Inc. (KTRA:NASDAQ)
Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs.
Top 10 Gainers:
- Corbus Pharmaceuticals Holdings, Inc. (CRBP:NASDAQ), 97.59%
- OncoCyte Corporation (OCX:NASDAQ), 51.5%
- Baudax Bio, Inc. (BXRX:NASDAQ), 44.36%
- ThermoGenesis Holdings, Inc. (THMO:NASDAQ), 43.2%
- PureCycle Technologies Inc. (PCT:NASDAQ), 39.41%
- Lipella Pharmaceuticals Inc. (LIPO:NASDAQ), 39.11%
- Kintara Therapeutics Inc. (KTRA:NASDAQ), 34.04%
- Peak Bio Inc Com (PKBO:NASDAQ), 31.56%
- Genelux Corporation (GNLX:NASDAQ), 27.78%
- Boqii Holding Limited American Depositary Shares representing Class A (BQ:NYSE), 25.81%